Activation of checkpoint cascades such as those controlled by PD-1 or PD-L1 will result in inactivation of tumor-specific T cells and immune evasion (Iwai et al., 2002; Dunn et al., 2004; Brown et al., 2010). Here, CD274 is linked to neoplasm.